CAMK2-related brain disorders natural history study
Part of Brain & nervous system clinical trials.
This study tracks the health and development of people with a specific genetic change in the CAMK2 genes. By joining, you help researchers understand the condition better, which may lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a genetic test showing a likely harmful change in a CAMK2 gene (called a pathogenic or likely pathogenic variant).
- You must agree to have your anonymous information added to a national or international database for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies CADASIL (a genetic blood-vessel condition in the brain) by following people over time with MRI scans, blood draws, and questionnaires. It may help researchers better understand how the condition changes and how factors like medications affect outcomes.
This study tracks the health of people with a confirmed ACTA2 gene change over time to better understand the disease. It may help researchers learn how to improve care for this condition.
This study follows people with a hereditary form of cavernous malformations (clusters of abnormal blood vessels in the brain). It aims to understand how the condition changes over time, without testing any new treatments.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study collects blood samples and medical information from people with rare inherited blood vessel diseases of the brain, and from healthy volunteers. Researchers use this information to understand these diseases better and develop future treatments.
This study is creating a registry to track the health of people who have specific genetic changes that cause epilepsy and uncontrolled movements (dyskinesia). It may help researchers better understand these conditions and how they change over time.
Hear when a new CAMK2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.